Neonatal Gram Negative and Candida Sepsis Survival and Neurodevelopmental Outcome at the Corrected Age of 24 Months

Abstract

Objectives

To evaluate the long term neurodevelopmental outcome of premature infants exposed to either gram- negative sepsis (GNS) or neonatal Candida sepsis (NCS), and to compare their outcome with premature infants without sepsis.

Methods

Historical cohort study in a population of infants born at <30 weeks gestation and admitted to the Neonatal Intensive Care Unit (NICU) of the Academic Medical Center in Amsterdam during the period 1997–2007. Outcome of infants exposed to GNS or NCS and 120 randomly chosen uncomplicated controls (UC) from the same NICU were compared. Clinical data during hospitalization and neurodevelopmental outcome data (clinical neurological status; Bayley –test results and vision/hearing test results) at the corrected age of 24 months were collected. An association model with sepsis as the central determinant of either good or adverse outcome (death or severe developmental delay) was made, corrected for confounders using multiple logistic regression analysis.

Results

Of 1362 patients, 55 suffered from GNS and 29 suffered from NCS; cumulative incidence 4.2% and 2.2%, respectively. During the follow-up period the mortality rate was 34% for both GNS and NCS and 5% for UC. The adjusted Odds Ratio (OR) [95% CI] for adverse outcome in the GNS group compared to the NCS group was 1.4 [0.4–4.9]. The adjusted ORs [95% CI] for adverse outcome in the GNS and NCS groups compared to the UC group were 4.8 [1.5–15.9] and 3.2 [0.7–14.7], respectively.

Conclusions

We found no statistically significant difference in outcome at the corrected age of 24 months between neonatal GNS and NCS cases. Suffering from either gram –negative or Candida sepsis increased the odds for adverse outcome compared with an uncomplicated neonatal period.

About the Authors:

Timo R. de Haan

* E-mail: [email protected]

Affiliation: Department of Neonatology, Emma Children’s Hospital, Academic Medical Center Amsterdam, The Netherlands

Loes Beckers

Affiliation: Department of Neonatology, Emma Children’s Hospital, Academic Medical Center Amsterdam, The Netherlands

Rogier C. J. de Jonge

Affiliation: Department of Neonatology, Erasmus MC – Sophia Children’s Hospital, Rotterdam, The Netherlands

Lodewijk Spanjaard

Affiliation: Department of Microbiology, Academic Medical Center, Amsterdam, The Netherlands

Letty van Toledo

Affiliation: Department of Neonatology, Emma Children’s Hospital, Academic Medical Center Amsterdam, The Netherlands

Dasja Pajkrt

Affiliation: Department of Pediatric Infectious Diseases, Academic Medical Center Amsterdam, The Netherlands

Aleid G. van Wassenaer-Leemhuis

Affiliation: Department of Neonatology, Emma Children’s Hospital, Academic Medical Center Amsterdam, The Netherlands

Johanna H. van der Lee

Affiliation: Department of Pediatric Clinical Epidemiology, Emma Children’s Hospital, Academic Medical Center, Amsterdam, The Netherlands

Introduction

Nosocomial infections caused by gram negative and Candida sepsis in the Neonatal Intensive Care Unit (NICU) may lead to overt clinical sepsis increasing the risk for mortality, co- morbidity and long-term neurodevelopmental sequelae [1]–[3]. Extremely Low Birth Weight (ELBW) and Very Low Birth Weight (VLBW) infants are the most fragile and immunologically compromised patients in the NICU [2], [4], [5]. Well known risk factors for nosocomial sepsis in this population are surgery (mostly for Necrotising Entero Colitis, NEC), prolonged ventilatory support, the use of total parenteral nutrition (TPN), indwelling central venous catheters (CVC), corticosteroid medication use and the frequent use of broad-spectrum antibiotics [2], [6]–[10].

Sepsis episodes caused by gram- negative bacteria (gram- negative sepsis; GNS) and neonatal Candida sepsis (NCS) are both associated with high mortality and morbidity rates, ranging from 19–36% and 32–44% respectively [1], [2], [9]–[11]. The reported cumulative incidence of GNS in the NICU varies from 2.7 to 4.4% [3], [12], [13], compared with 1.7 to 9.0% [3], [6], [10], [12] for NCS. In GNS Escherichia coli and Klebsiella pneumoniae are the most frequently encountered microorganisms [7], [14], [15]. Most commonly reported causative microorganisms in NCS are Candida albicans and Candida parapsilosis [6], [16].

Long- term neurological sequelae of GNS and NCS in VLBW infants have been reported in 45% and 57% of exposed infants respectively [3]. The presence of meningitis during neonatal sepsis is a major additional risk factor for adverse outcome [4], [17].

Reports on the long-term outcome of infants suffering nosocomial sepsis are sparse. The aim of this study was therefore to investigate the odds for adverse outcome (death or severe neurodevelopmental delay) in infants with a gestational age <30 weeks admitted at a tertiary NICU suffering either GNS or NCS in comparison with the outcome of infants without sepsis.

Methods

Research Design and Population

Data from a historical cohort were used. The basic population consisted of all infants born at a gestational age <30 weeks admitted to the NICU of the Academic Medical Center (AMC), Amsterdam, The Netherlands between January 1^st 1997 and December 31^st 2007.

All neonates from this population with a bacteriological diagnosis of either gram-negative sepsis (GNS) or neonatal Candida sepsis (NCS) (only positive peripheral blood cultures) were included to compare the long- term outcome of these cases.

In order to compare the long- term outcome of GNS and NCS with the outcome of uncomplicated neonatal infants (no sepsis but undergoing identical NICU care) admitted at the same NICU during the same time period and undergoing the same routine care, we randomly selected a set of neonates, without any type of sepsis, from the remaining cases of the same population (UC group). For each case of GNS or NCS, at least 2 control subjects were randomly selected by choosing every other 5^th subject from the same basic population. From February to December 2011 clinical and microbiological data were obtained retrospectively from existing written and partly digital medical files, the digital records of the Patient Data Management System (PDMS), the digital clinical chemistry and medical microbiological laboratory databases and the digital long- term follow–up database of the NICU (FUN database).

As existing clinical data were used, collected during the clinical course of these patients and as analyses and reporting of these data was performed anonymously, the approval of the institutional medical ethical committee or signed parental consent were not needed for this research according to Good Clinical Practice - and local legislation, including the Data Protection Act (Wet Bescherming Persoonsgegevens; WBP) and the Medical Contract Bill (Wet Geneeskundige Behandelings-overeenkomst); WGBO.

Study Population

Inclusion and exclusion criteria.

Patients were included in the GNS or NCS group only when when either gram-negative bacteria or Candida species were found in peripheral blood cultures and if patients were defined as having a clinical sepsis (see below). Only the microorganisms found in the blood cultures were deemed as the causative organism for the sepsis episode.

Patients were not included in these study-groups if only positive central line cultures were found for either yeast or gram negative bacteria as central line culture results may be misleading.

Clinical sepsis was defined as having at least two of the following symptoms: 1) any increase in frequency or duration of apnoea or bradycardia episodes (not related to feeding problems or airway obstruction) necessitating an increase in ventilatory support (intubation and ventilation; Nasal Intermittent Positive Pressure Ventilation; or increase in Continuous Positive Airway Pressure ); 2) hypothermia (core body temperature of <36.5°C) or hyperthermia (core body temperature of >38.5°C); 3) circulatory compromise: a systolic blood pressure <P5 according to gestational age corrected values.

Patients were included as uncomplicated control group (UC group) subjects if 1) during hospital stay no clinical or bacteriological signs of infection (sterile blood cultures on admission) were identified; 2) either ventilatory support by infant flow CPAP or short (<72 hrs.) ventilation for infant respiratory distress (IRDS) was given and 3) they had received routine NICU care (including indwelling catheters and parenteral nutrition). All infants with possible syndromal traits were excluded.

Measures

Long-term neurodevelopment and outcome measures.

Outcome was defined as adverse in infants who either 1) died or 2) suffered cerebral palsy either alone or in combination with clinical hearing loss or visual handicaps (mostly ROP) or 3) had MDI/PDI BSID-II-NL results <85.

Post discharge mortality was investigated by evaluating discharge letters and obtaining information from treating physicians in all patients for the follow-up period of the study (24 months corrected age). For all infants the neurodevelopmental outcome was assessed at the corrected age of 24 months by a trained neuropsychologist using the Bayley Scales of Infant Development (Second Edition-Dutch version: BSID-II-NL) [18], [19]. This comprises three separate scales (mental scale, motor scale and behavioral rating). Mental and motor scale scores are converted to a mental developmental index (MDI) and a psychomotor developmental index (PDI) with a mean of 100 and a standard deviation (SD) of 15. Normal limits are defined as MDI and PDI values between 85 and 114. Values of 70–84 are defined as mildly delayed. A score of <70 is defined as severely delayed [20]. The BSID-II has been shown to be reproducible and valid [18], [19]. All infants also underwent a standardised neurological examination performed by trained paediatricians. Some neonatologists of the NICU participate in the long term neonatal follow up program of our hospital. Also digital medical data were available for review for the neuropsychologists and paediatricians performing the outcome assessments. Therefore (and because of the retrospective nature of this study) neurodevelopmental assessment was not blinded for the clinical history.

Outcome was defined as good in survivors with a normal neurological examination, no evidence of hearing loss or visual impairment and Mental Developmental Index (MDI)/Psychomotor Developmental Index (PDI) BSID –II-NL score >85. Hearing investigation (newborn hearing screening: digital data) and specialist ophthalmic investigation results (screening for ROP) were digitally available for all cases.

Clinical Information

Information was retrieved from the medical files on: the time (in days) to the onset of sepsis (counted from the date of admission); total duration of hospitalization (in days), birth weight (grams), gestational age (weeks), Apgar scores, total duration of ventilatory (either intubation and ventilation or CPAP) or inotropic support, total duration of parenteral nutrition and indwelling CVC (all in days). The need for invasive surgical procedures was recorded as well as use of corticosteroid medication.

The following variables were recorded in a dichotome manner: 1) presence of bacterial meningitis; 2) abnormal cerebral ultrasound result (defined as any abnormality detected); 3) presence of retinopathy of prematurity (ROP) [21], [22]; 4) the presence of bronchopulmonary dysplasia (BPD) (defined as the need for supplemental oxygen at 36 weeks postmenstrual age) [23], [24]; 5) abnormal newborn hearing (ALGO) screening result.

To evaluate disease severity at the start of sepsis the Neonatal Therapeutic Intervention Scoring System (NTISS, range 0 to 130) was recorded as a continuous variable. This instrument assesses severity of illness by quantifying the intensity and complexity of care received by a patient. It is based on the assumption that therapeutic intensity is a direct correlate of illness severity, given similar philosophies or styles of care. [25]. The systematic use of the NTISS score was implemented in our unit in 1999.

Microbiology Data

Microbiological information was recorded on the basis of the blood culture results only. According to the clinical protocol all peripheral blood cultures had been taken prior to start of any antimicrobial therapy. The diagnosis of meningitis was considered as proven only when CSF cultures were positive. Blood cultures were incubated in a semi-automatic system, the BacT/Alert (bioMerieux, Boxtel, the Netherlands). For a blood culture a minimum of 2.0 ml of blood was taken and divided over two bottles (FAN-aerobic: 1.0 ml & FAN-anaerobic: 1.0 ml). Susceptibility to antibacterial and antimycotic agents was determined on Isosensitest and RPMI-plates respectively using disk diffusion (Rosco, Taastrup, Denmark) or on MH plates with E-test (bioMerieux) according to the manufacturers’ instructions. Multiple positive cultures with the same causative microorganism within 7 days were interpreted as one identical sepsis episode. Multiple sepsis episodes were defined as consecutive episodes of clinical sepsis with positive blood cultures with a disease free interval of at least 7 days.

Statistical Analysis

Statistical analysis was performed with SPSS 18.0 statistical software package (SPSS Inc., Chicago, IL). Independent samples t-tests were used to compare sample means of continuous clinical variables between the GNS and the NCS cohort and between each cohort and the control group. Skewed data were log- transformed. The Mann-Whitney-U test was performed if data were not distributed normally and log transformation did not result in a normal distribution. The Chi squared-test was used for the analysis of nominal data. Differences were considered statistically significant when 2-tailed p-values were <0.05.

To analyse the association between the central determinant “sepsis exposure” (GNS, NCS or UC) and outcome (defined as either “adverse” or “good”) multiple logistic regression analysis was performed. Two association models were produced, one crude model unadjusted for confounding and a model adjusted for confounders.

Adjusted estimates for cohort type as a risk factor for adverse outcome were obtained by entering potential confounders in the model one by one. The presence of confounding, defined as a change in the regression coefficient of the central determinant (i.e. cohort type) of >10%, and effect modification, defined as a statistically significant effect of an interaction term, was investigated for all potential confounders in the model in a pre-defined order. Potential confounders were: gestational age; birth weight; total duration of hospitalization (in days); duration of central venous catherization and parenteral nutrition (days); duration of inotropic and ventilatory support (in days); duration of CPAP support (in days); ALGO and ROP screening results; BPD diagnosis at 36 weeks PMA; multiple episodes of infection; neonatal NTISS score and ultrasound result. The presence of co-linearity was investigated by simultaneously adding two co- variables to the regression model that were suspected to cause co-linearity based on a high mutual correlation (e.g. duration of ventilatory and CPAP support). Either a large change in the standard error or a change of the direction of the regression coefficient of these co variables compared with a model containing only one of the 2 co -variables was interpreted as co-linearity.

Results

Candida Sepsis, Gram-negative Sepsis and Control Subjects

During the period of 1997–2007, 1362 patients with a gestational age <30 weeks were admitted at the NICU of the AMC. In the study period 57 patients had a positive peripheral blood culture for gram-negative bacteria. Two patients were excluded from this group because there were no clinical signs of sepsis and no positive blood cultures were noted (only a positive central line culture), leaving a group of 55 cases (cumulative incidence 4%). In the same study period there were 31 patients with a peripheral positive blood culture for yeast sepsis; 2 patients were excluded from this group because there were no clinical signs of sepsis and no positive blood cultures were noted (only a positive central line culture), leaving a group of 29 cases (cumulative incidence 2%). There were no patients in our study with only a positive central-line culture and signs of sepsis.

The control group consisted of 120 infants with an uncomplicated clinical course as defined above. The population flow chart is demonstrated in figure 1. Table 1 demonstrates the characteristics of the GNS, NCS and UC groups. Infants who developed GNS and NCS had significantly smaller birth weights than the UC (p<0.001.

[Figure omitted. See PDF.]

Figure 1. Population Flow sheet.

LFUP: Long Term Follow Up completed; LTF: Loss to follow up.

https://doi.org/10.1371/journal.pone.0059214.g001

[Figure omitted. See PDF.]

Table 1. Population Characteristics.

https://doi.org/10.1371/journal.pone.0059214.t001

Main Study Outcome: Adverse Long-term Neurodevelopment or Demise

Mortality was highly comparable between the GNS and NCS groups (19/55 and 10/29 respectively). All deaths occurred during admission at the NICU.

As Figure 1 demonstrates, the loss to follow–up at the corrected age of 24 months was limited (8%). Table 2 demonstrates the neurodevelopmental outcome results in detail.

[Figure omitted. See PDF.]

Table 2. Neurodevelopmental outcome in detail.

https://doi.org/10.1371/journal.pone.0059214.t002

At follow –up of the NCS group normal vision was noted in 82% and normal hearing was observed in 76%. The outcome of the clinical neurological exam was normal in 41% of the patients.

In the GNS group normal vision was noted in 70% and in 82% there was no hearing impairment. The outcome of the clinical neurological examination was normal in 55% of the patients.

In the uncomplicated control group (UC) 92% had no vision impairment and 99% had no hearing impairment. The outcome of the clinical neurological examination was normal in 85%.

Combining these findings with the available BSID test results and the mortality results, adverse outcome was noted in 48% of the NCS; 56% of the GNS group and 16% of the UC group.

The statistical analyses demonstrated no statistically significant difference in the odds for adverse outcome (either death or severe neurodevelopmental delay) between the GNS and NCS infants or between the NCS group and the UC group but the OR [95% CI] for adverse outcome in the GNS group compared to the UC group was 4.8 [1.5–15.9]. The crude and adjusted odds ratios (OR) estimated in the regression models are demonstrated in table 3. Effect modification was not found. Co-linearity was found for the duration of indwelling CVC and total duration of parenteral nutrition and for duration of intubation and ventilation and CPAP support. The dichotomous covariable of meningitis and the ordinal covariable “maternal education type” could not be entered in the model as unfortunately >50% of data was missing for both. The events of either surgery for NEC or suffering multiple sepsis episodes did not influence our findings concerning the odds for adverse outcome.

[Figure omitted. See PDF.]

Table 3. Raw and adjusted association (Odds Ratios) between sepsis type and adverse outcome.

https://doi.org/10.1371/journal.pone.0059214.t003

The Clinical Course

Clinical parameters are also shown in table 1. There were no statistically significant differences in any of the clinical parameters between GNS and NCS cases. For gram-negative sepsis Klebsiella pneumoniae, E. coli and Enterobacter cloacae were the most common causative pathogens. The most common causative species for Candida sepsis were C. albicans and C. parapsilosis. Multiple sepsis episodes occurred in both sepsis groups. In the yeast sepsis group 45% of the patients had experienced multiple episodes of sepsis, compared to 20% of the patients in the gram-negative sepsis group. Table 4 demonstrates the species found in the bloodcultures during these multiple sepsis episodes. During the study period, antimycotic prohylaxis was not prescribed.

[Figure omitted. See PDF.]

Table 4. Distribution of Pathogens and Multiple Episodes.

https://doi.org/10.1371/journal.pone.0059214.t004

Retinopathy and Bronchopulmonary Dysplasia

The cumulative incidences of ROP and BPD are shown in table 1. In the GNS group ROP screening results were available for all patients (n = 55). Abnormal results were found in 13 infants (24%) (stage 1: n = 5; stage 2: n = 3; stage 3: n = 5). BPD was diagnosed in 9/55 infants (16%).

In the Candida sepsis group ROP screening results were available for 27/29 infants (93%). Abnormal results were found in 8 infants (30%) (stage 1: n = 3; stage 2: n = 2; stage 3: n = 3). BPD was diagnosed in 7/29 infants (24%).

In the uncomplicated controls ROP screening results were available for all 120 infants. Abnormal results were found in 12 infants (10%) (stage 1: n = 10; stage 2: n = 1; stage3: n = 1). Two infants were diagnosed with BPD (2%).

Discussion

Our data did not demonstrate any statistically significant difference in the odds for adverse outcome between GNS and NCS cases. In a comparable report by Stoll et al. evaluating outcome of neonatal sepsis in ELBW infants at the corrected ages of 18 and 22 months no significant difference was found between NCS and GNS cases either [3]. Outcome was however not compared to neonatal controls without sepsis in their report. In our study the OR for adverse outcome comparing the GNS and NCS group with UC was high, emphasizing the devastating effect of sepsis on long-term outcome and mortality. It is important to compare our study population to those of previous reports. The incidence of GNS of 4% in our population was comparable to previously reported incidences of 2.7–4.4% [9], [26]. The incidence of NCS in our population was 2%, which is also in accordance with reported incidence of 1.9–9.0% [1], [8], [10]. The mortality rate of 34% for both the GNS and NCS cases was comparable to the mortality ranges as reported previously (19–36%, and 32–44% respectively) [2], [9]–[11]. In line with previous findings, infants suffering clinical sepsis were generally smaller in birth weight than infants with an uncomplicated course [1]–[3], [27].

The distribution of both the Candida species and the gram-negative species in our study population is comparable to previous reports [6], [7], [14]–[16]. This is important in view of the comparison of our results with known international results on outcome of neonatal sepsis cases. During the study period antimycotic prophylaxis was not prescribed to any infant.

The only difference between our study population and earlier described groups seems to be the prevalence of ROP and of BPD. Cumulative ROP incidences have been reported in 51% of children after GNS and in 67–86% of children after NCS [21], [28], [29]. In our study we found a cumulative ROP incidence of 30% in the NCS cohort and of 24% in the GNS cohort, which is lower than previously reported. The high awareness for oxygen radical damage and close ophthalmological monitoring and follow-up in our cohort may have contributed to these low incidences of ROP as continued inflammation and oxygen use are risk factors for sepsis associated morbidities such as BPD and ROP.

Also, the cumulative incidence of BPD in our population, 16% in the GNS cohort and 24% in the NCS cohort, was low compared to previously published reports [3], [30], [31]. This may be explained by the fact that in our study infants below 25 weeks GA with a high risk for pulmonary complications were not present. At that time infants below a gestational age of 25 weeks were not actively treated in the Netherlands.

As far as we know this is the first report comparing outcome between neonates experiencing NCS or GNS with the outcome of uncomplicated controls admitted at the same NICU and treated with the same routine NICU care. This was made possible by highly digitalized databases in which both the clinical course and long- term outcome is registered for the entire NICU population of infants born at a gestational age below 30 weeks. The loss to follow- up in our population was limited as a result of a standardized policy of long term follow- up.

This study has several limitations. Maternal education was not recorded in the early years of the study period and lumbar punctures were not routinely included in the protocol for sepsis work-up until the latter half of the study period. So for both these important factors that may be important for outcome (the presence of meningitis and maternal education) insufficient data were available. This may have influenced our results. Also it is possible that infants with false negative culture results, but with clinical sepsis, were not included in this data set as they were not retrieved by our search from the microbiology databases.

Since this study was performed retrospectively, neurodevelopmental clinicians and neuropsychologists of our outpatient clinic were not blinded for the medical history and outcome evaluation may have differed between sepsis cohort infants and control infants. This information bias may have lead to overestimation of the effect of sepsis.

Another limitation of the study might be that it contains a relatively small number of sepsis cases, especially in the NCS cohort. The comparison of the distribution of clinical characteristics between the NCS cohort and the GNS cohort and the analysis of the long-term outcome demonstrated no statistically significant differences. However, due to the small number of cases a type II error cannot be excluded. From a clinical perspective, the increased ORs for adverse outcome due to a clinical sepsis with inflammatory damage by itself are probably much more important than the specific causative organism as is demonstrated viewing the ORs for adverse outcome comparing both GNS and NCS groups with uncomplicated controls. Clinical experience supports these outcome data. However, larger prospective multicentre studies are needed to construct possible prediction models for neonatal sepsis and its outcome.

Author Contributions

Reviewed manuscript: LS. Conceived and designed the experiments: TRH RCJJ. Performed the experiments: TRH LB RCJJ. Analyzed the data: TRH RCJJ JHL. Contributed reagents/materials/analysis tools: LS. Wrote the paper: TRH LB RCJJ LT DP AGWL JHL.

Citation: de Haan TR, Beckers L, de Jonge RCJ, Spanjaard L, van Toledo L, Pajkrt D, et al. (2013) Neonatal Gram Negative and Candida Sepsis Survival and Neurodevelopmental Outcome at the Corrected Age of 24 Months. PLoS ONE 8(3): e59214. https://doi.org/10.1371/journal.pone.0059214

References

1. Benjamin DK, Jr., Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD(2006) Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117: 84–92. 117/1/84 [pii];10.1542/peds.2004-2292 [doi].

2. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA (2002) Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110: 285–291.

3. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR (2004) Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292: 2357–2365. 292/19/2357 [pii];10.1001/jama.292.19.2357 [doi].

4. Moylett EH (2003) Neonatal Candida meningitis. Semin Pediatr Infect Dis 14: 115–122.

5. Saigal S, Doyle LW (2008) An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371: 261–269. S0140-6736(08)60136-1 [pii];10.1016/S0140-6736(08)60136-1 [doi].

6. Benjamin DK, Jr., Stoll BJ, Gantz MG, Walsh MC, Sanchez PJ, Das A (2010) Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 126: e865-e873. peds.2009-3412 [pii];10.1542/peds.2009-3412 [doi].

7. Stoll BJ, Hansen N (2003) Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 27: 293–301.

8. Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Mirza SA (2005) Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998–2000. Pediatr Infect Dis J 24: 601–604. 00006454-200507000-00006 [pii].

9. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R (2005) Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003. Pediatr Infect Dis J 24: 635–639. 00006454-200507000-00013 [pii].

10. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, et al. (2000) Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 19: 319–324.

11. Lopez Sastre JB, Coto Cotallo GD, Fernandez CB (2003) Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 20: 153–163. 10.1055/s-2003-40008 [doi].

12. Benjamin DK, DeLong E, Cotten CM, Garges HP, Steinbach WJ (2004) Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol 24: 175–180. 10.1038/sj.jp.7211068 [doi];7211068 [pii].

13. Samanta S, Farrer K, Breathnach A, Heath PT (2011) Risk factors for late onset gram-negative infections: a case-control study. Arch Dis Child Fetal Neonatal Ed 96: F15-F18. adc.2009.169540 [pii];10.1136/adc.2009.169540 [doi].

14. Khassawneh M, Khader Y, Abuqtaish N (2009) Clinical features of neonatal sepsis caused by resistant Gram-negative bacteria. Pediatr Int 51: 332–336. PED2767 [pii];10.1111/j.1442-200X.2008.02767.x [doi].

15. Gordon A, Isaacs D (2006) Late onset neonatal Gram-negative bacillary infection in Australia and New Zealand: 1992–2002. Pediatr Infect Dis J 25: 25–29. 00006454–200601000–00007 [pii].

16. Benjamin DK Jr, Garges H, Steinbach WJ (2003) Candida bloodstream infection in neonates. Semin Perinatol 27: 375–383.

17. Doctor BA, Newman N, Minich NM, Taylor HG, Fanaroff AA, Hack M (2001) Clinical outcomes of neonatal meningitis in very-low birth-weight infants. Clin Pediatr (Phila) 40: 473–480.

18. Jary S, Kmita G, Whitelaw A (2011) Differentiating Developmental Outcome between Infants with Severe Disability in Research Studies: The Role of Bayley Developmental Quotients. J Pediatr.

19. Leonard CH, Piecuch RE, Cooper BA (2001) Use of the Bayley Infant Neurodevelopmental Screener with low birth weight infants. J Pediatr Psychol 26: 33–40.

20. Bayley N (2011) Bayley Scales of Infant Development, second edition. San Antonio. The Psychological Corporation. 1993.

21. Chen M, Citil A, McCabe F, Leicht KM, Fiascone J, et al. (2011) Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity. Neonatology 99: 125–132. 000312821 [pii];10.1159/000312821 [doi].

22. Committee for the Classification of Retinopathy of Prematurity (1984) An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 102: 1130–1134.

23. Bancalari E, Claure N, Sosenko IR (2003) Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 8: 63–71. S1084275602001926 [pii].

24. Bancalari E, Claure N (2006) Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol 30: 164–170.

25. Gray JE, Richardson DK, McCormick MC, Workman-Daniels K, Goldmann DA (1992) Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics 90: 561–567.

26. Pereira SM, de Almeida Cardoso MH, Figuexeds AL, Mattos H, Rozembaum R, et al. (2009) Sepsis-Related Mortality of Very Low Birth Weight Brazilian Infants: The Role of Pseudomonas aeruginosa. Int J Pediatr 2009: 427682. 10.1155/2009/427682 [doi].

27. Downey LC, Smith PB, Benjamin DK Jr (2010) Risk factors and prevention of late-onset sepsis in premature infants. Early Hum Dev 86 Suppl 1: 7–12. S0378–3782(10)00014-9 [pii];10.1016/j.earlhumdev.2010.01.012 [doi].

28. Manzoni P, Maestri A, Leonessa M, Mostert M, Farina D, Gomirato G (2006) Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates. J Perinatol 26: 23–30.

29. Bharwani SK, Dhanireddy R (2008) Systemic fungal infection is associated with the development of retinopathy of prematurity in very low birth weight infants: a meta-review. J Perinatol 28: 61–66. 7211878 [pii];10.1038/sj.jp.7211878 [doi].

30. Makhoul IR, Bental Y, Weisbrod M, Sujov P, Lusky A, Reichman B (2007) Candidal versus bacterial late-onset sepsis in very low birthweight infants in Israel: a national survey. J Hosp Infect 65: 237–243. S0195-6701(06)00518-4 [pii];10.1016/j.jhin.2006.12.004 [doi].

31. Klinger G, Levy I, Sirota L, Boyko V, Lerner-Geva L, Reichman B (2010) Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics 125: e736–e740. peds.2009-2017 [pii];10.1542/peds.2009-2017 [doi].